Synthesis and Biological Activity of 23-Hydroxybetulinic Acid C-28 Ester Derivatives as Antitumor Agent Candidates

被引：18

作者：

Bi, Yi ^{[2
]}

Xu, Jinyi ^{[1
,3
]}

Sun, Fei ^{[1
]}

Wu, Xiaoming ^{[3
]}

Ye, Wencai ^{[4
]}

Sun, Yijun ^{[5
]}

Huang, Wenwen ^{[2
]}

机构：

[1] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China

[2] Yantai Univ, Sch Pharm, Yantai 264005, Shandong, Peoples R China

[3] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China

[4] China Pharmaceut Univ, Dept Phytochem, Nanjing 210009, Jiangsu, Peoples R China

[5] Nanjing KeyGen Biotech Co Ltd, Drug Screening Ctr, Nanjing 210012, Jiangsu, Peoples R China

来源：

MOLECULES | 2012年 / 17卷 / 08期

关键词：

23-hydroxybetulinic acid; C-28 ester derivatives; antitumor activity; structure-activity relationships; BETULINIC ACID;

D O I：

10.3390/molecules17088832

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

23-Hydroxybetulinic acid (1) served as the precursor for the synthesis of C-28 ester derivatives. The target compounds were evaluated in vitro for their antitumor activities against five cell lines (A549, BEL-7402, SF-763, B16 and HL-60). Among the obtained compounds, 6i had the most potent antitumor activity, with the IC50 values of 8.35 mu M in HL-60 cells and showed similar antitumor activity as cyclophosphamide in H22 liver tumor and as 5-fluorouracil in B16 melanoma in vivo.

引用

页码：8832 / 8841

页数：10

共 12 条

[1] A Review of Natural and Modified Betulinic, Ursolic and Echinocystic Acid Derivatives as Potential Antitumor and Anti-HIV Agents [J].

Baglin, I. ;

Mitaine-Offer, A. -C. ;

Nour, M. ;

Tan, K. ;

Cave, C. ;

Lacaille-Dubois, M. -A. .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2003, 3 (06) :525-539

[2] Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives [J].

Bi, Yi ;

Xu, Jinyi ;

Wu, Xiaoming ;

Ye, Wencai ;

Yuan, Shengtao ;

Zhang, Luyong .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) :1475-1478

[3] Sensitization for anticancer drug-induced apoptosis by betulinic acid [J].

Fulda, S ;

Debatin, KM .

NEOPLASIA, 2005, 7 (02) :162-170

[4]

Heather J. F., 2002, ARKIVOC, V12, P38

[5] 23-Hydroxybetulinic acid-mediated apoptosis is accompanied by decreases in bcl-2 expression and telomerase activity in HL-60 Cells [J].

Ji, ZN ;

Ye, WC ;

Liu, GG ;

Hsiao, WLW .

LIFE SCIENCES, 2002, 72 (01) :1-9

[6] Betulinic acid and its derivatives as anti-angiogenic agents [J].

Mukherjee, R ;

Jaggi, M ;

Rajendran, P ;

Siddiqui, MJA ;

Srivastava, SK ;

Vardhan, A ;

Burman, AC .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2181-2184

[7] DISCOVERY OF BETULINIC ACID AS A SELECTIVE INHIBITOR OF HUMAN-MELANOMA THAT FUNCTIONS BY INDUCTION OF APOPTOSIS [J].

PISHA, E ;

CHAI, H ;

LEE, IS ;

CHAGWEDERA, TE ;

FARNSWORTH, NR ;

CORDELL, GA ;

BEECHER, CWW ;

FONG, HHS ;

KINGHORN, AD ;

BROWN, DM ;

WANI, MC ;

WALL, ME ;

HIEKEN, TJ ;

DASGUPTA, TK ;

PEZZUTO, JM .

NATURE MEDICINE, 1995, 1 (10) :1046-1051

[8] New betulinic acid derivatives induce potent and selective antiproliferative activity through cell cycle arrest at the S phase and caspase dependent apoptosis in human cancer cells [J].

Santos, Rita C. ;

Salvador, Jorge A. R. ;

Cortes, Roldan ;

Pachon, Gisela ;

Marin, Silvia ;

Cascante, Marta .

BIOCHIMIE, 2011, 93 (06) :1065-1075

[9]

Wu X.M., 2006, Patent No. [CN 200610040277, 200610040277]

[10]

Ye WC, 1996, PHYTOCHEMISTRY, V42, P799, DOI 10.1016/0031-9422(96)00043-X

← 1 2 →